Skip to content

Medical emergency? What to do

U.S. drops trial of one AIDS vaccine

3-RXPublished July 19, 20083 min read

Key points

  • AIDS researchers are dropping plans to test one experimental vaccine in people, saying the high-profile failure of a Merck and Co. vaccine last year shows the need to do quicker, more focused studies.
  • "However, NIAID believes the vaccine developed by its Vaccine Research Center (VRC) is scientifically intriguing and sufficiently different from previously tested HIV vaccines to consider testing it in a smaller, more focused clinical study," the institute said in a statement.
  • The vaccine used a common virus known as an adenovirus to carry bits of the AIDS virus.
  • The new vaccine being tested by the Partnership for AIDS Vaccine Evaluation, or PAVE, was designed to be given as three injections of HIV genetic material, followed with a final boost of adenovirus.

U.S. AIDS researchers are dropping plans to test one experimental vaccine in people, saying the high-profile failure of a Merck and Co. vaccine last year shows the need to do quicker, more focused studies.

The National Institute of Allergy and Infectious Diseases, part of the government's National Institutes of Health, said on Thursday it was canceling the HIV vaccine study known as PAVE 100.

"However, NIAID believes the vaccine developed by its Vaccine Research Center (VRC) is scientifically intriguing and sufficiently different from previously tested HIV vaccines to consider testing it in a smaller, more focused clinical study," the institute said in a statement.

It is the first demonstration of a new approach being taken by federal vaccine developers after a trial called STEP showed last year that Merck's vaccine may have raised the risk of infection among certain men -- those who had pre-existing immune responses to the virus used in the vaccine and who were not circumcised.

The vaccine used a common virus known as an adenovirus to carry bits of the AIDS virus. "It didn't work, it wasn't beneficial and there were the issues of risk for people who were uncircumcised," NIAID director Dr. Anthony Fauci said in a telephone interview.

"I am entertaining a smaller, leaner, less-expensive trial," Fauci added.

The new vaccine being tested by the Partnership for AIDS Vaccine Evaluation, or PAVE, was designed to be given as three injections of HIV genetic material, followed with a final boost of adenovirus.

"I do believe that it is worthwhile pursuing this concept of a DNA vaccine, but I don't believe that we have enough information to warrant making that a large trial," Fauci said.

Scientists had argued whether it was justified to go ahead with a large trial of a vaccine that could not be expected to protect people against infection in the hope of finding something in their biological responses that could help design a better vaccine down the road.

AIDS has killed 25 million people since it was first identified in the 1980s and it infects 33 million people globally. There is no cure although a cocktail of drugs can keep the infection suppressed.

"An HIV vaccine continues to be our best hope for ending the HIV pandemic," the NIAID said.

"DIFFICULT PERIOD"

Fauci said he decided it would be better to do smaller, more focused tests and if and when one of those gets a result, to follow that lead.

"We are in an interesting and, some would say, difficult period," Fauci said. "The obvious empirical approaches have not worked."

But while about 30 vaccines are being tested, none has come even close to preventing infection in people.

"Because the PAVE vaccine candidate is different from the STEP candidate, we can still learn something from testing the PAVE candidate in humans. It's just not necessary to do so in a trial involving thousands, as called for in the PAVE 100 design," International AIDS Vaccine Initiative president Seth Berkley said in a statement.

By Maggie Fox
WASHINGTON (Reuters)

"The decision by NIAID does not reflect paralysis in the AIDS vaccine field, or a lack of direction forward. In fact, it reflects the opposite. It reflects the dynamic learning that is the scientific process, that is pharmaceutical product development," Berkley added.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underAIDS/HIV

Keep reading

AIDS/HIV

Economic crisis could worsen HIV/AIDS epidemic: UN

Economic crisis and climate change concerns could affect the fight against the AIDS virus and lead to a "universal nightmare", the head of the United Nations' agency for HIV/AIDS said on Sunday. The global economic…

2 min read

AIDS/HIV

Possible cure for HIV patients?

On December 7th, an article was published in PLoS One that explained that researchers from UCLA AIDS Institute have found a way to use human stem cells to fight HIV-infected cells. The human stem cells can be…

1 min read

AIDS/HIV

HIV-infected Chinese children struggle with stigma

The second storey of this nondescript building in Fuyang city in China's central province of Anhui houses HIV-positive orphans, but unlike many other similar establishments, there are no signboards outside. Heavy…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.